Contact
searchSearch
HMP Global

Crohn's Disease

Crohn's Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Bruce Sands
Expert Insights
Bruce Sands, MD, on Results from DUET-CD
05/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
05/19/2026
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Research Review
Miguel Regueiro, MD, on Therapies for Perianal Crohn's Disease
05/13/2026
Miguel D. Regueiro, MD
Dr Regueiro reviews his presentation from Digestive Disease Week on the treatment of perianal Crohn's disease, including advances in medical therapies and surgical approaches. 
Dr Regueiro reviews his presentation from Digestive Disease Week on the treatment of perianal Crohn's disease, including advances in medical therapies and surgical approaches. 
Dr Regueiro reviews his...
05/13/2026
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Conference Coverage
Edward Barnes, MD on the VIVID Trials of Mirikizumab in Bio-Exposed Patients With Crohn's Disease
05/06/2026
Edward L. Barnes, MD
Dr Barnes reviewed his presentation of results from the VIVID 1 and VIVID 2 trials of mirkizumab in patients with Crohn's disease with exposure to anti-TNF therapy, which found that 65% of those in endoscopic response at week 52 maintained...
Dr Barnes reviewed his presentation of results from the VIVID 1 and VIVID 2 trials of mirkizumab in patients with Crohn's disease with exposure to anti-TNF therapy, which found that 65% of those in endoscopic response at week 52 maintained...
Dr Barnes reviewed his...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Christina Ha
Conference Coverage
Early Advanced Therapy and Postoperative Monitoring Emerge as Priorities in Updated Crohn’s Disease Guidance
12/16/2025
Christina Ha, MD
Dr Christina Ha reinforced the progressive nature of CD and the need for objective, individualized decision-making across disease stages.
Dr Christina Ha reinforced the progressive nature of CD and the need for objective, individualized decision-making across disease stages.
Dr Christina Ha reinforced the...
12/16/2025
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Marla Dubinsky, MD, Reframes the First Steps in Crohn’s Disease
12/09/2025
Marla C. Dubinsky, MD
Dr Dubinsky told attendees at the Advances in IBD annual meeting that the time of diagnosis is a "golden moment" for the patient with newly diagnosed Crohn's disease.
Dr Dubinsky told attendees at the Advances in IBD annual meeting that the time of diagnosis is a "golden moment" for the patient with newly diagnosed Crohn's disease.
Dr Dubinsky told attendees at...
12/09/2025
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Conference Coverage
Laura Raffals, MD, on Choosing Therapy for Crohn's After Initial Failure
12/09/2025
Laura Raffals
Dr Raffals explains a framework for choosing a second therapy for the patient with Crohn's disease who did not respond, or lost response, to the first therapy.
Dr Raffals explains a framework for choosing a second therapy for the patient with Crohn's disease who did not respond, or lost response, to the first therapy.
Dr Raffals explains a framework...
12/09/2025
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on Updates in Post-Operative Crohn's Disease
12/09/2025
Miguel D. Regueiro, MD
Dr Regueiro provides updates on the care--and possible prevention of recurrence—of Crohn's disease following surgery, from his presentation at the 2025 AIBD Annual Meeting in Orlando, Florida.
Dr Regueiro provides updates on the care--and possible prevention of recurrence—of Crohn's disease following surgery, from his presentation at the 2025 AIBD Annual Meeting in Orlando, Florida.
Dr Regueiro provides updates on...
12/09/2025
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Tackling the Complications of Crohn's Disease
11/11/2025
David T. Rubin, MD
Dr Rubin reviews his lecture on managing the complications of Crohn's disease, from strictures and fibrosis to perianal disease, from the ACG Postgraduate Course.
Dr Rubin reviews his lecture on managing the complications of Crohn's disease, from strictures and fibrosis to perianal disease, from the ACG Postgraduate Course.
Dr Rubin reviews his lecture on...
11/11/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Florian Rieder, MD, on Stricturing and Penetrating Crohn's Disease
10/06/2025
Raymond Cross, MD; Florian Rieder
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes...
10/06/2025
Advances in Inflammatory Bowel Disease Network
Shirley Cohen Mekelburg
Conference Coverage
Shirley Cohen-Mekelburg, MD, on Penetrating and Stricturing Crohn's Disease
08/25/2025
Shirley Cohen-Mekelburg
Dr Cohen-Mekelburg recaps the key takeaways from her presentation at the AIBD regional meeting in Detroit on managing penetrating and stricturing Crohn's disease and perianal disease.
Dr Cohen-Mekelburg recaps the key takeaways from her presentation at the AIBD regional meeting in Detroit on managing penetrating and stricturing Crohn's disease and perianal disease.
Dr Cohen-Mekelburg recaps the...
08/25/2025
Advances in Inflammatory Bowel Disease Network

Latest News

Research Highlights
Combined Ultrasound and Calprotectin at 3 Months Predict Postoperative Recurrence in Crohn’s Disease
05/07/2026
Jessica Garlewicz
High specificity and positive predictive value suggest that patients meeting both thresholds are at high risk for early recurrence and may need closer monitoring.
High specificity and positive predictive value suggest that patients meeting both thresholds are at high risk for early recurrence and may need closer monitoring.
High specificity and positive...
05/07/2026
Advances in Inflammatory Bowel Disease Network
News
Oral Icotrokinra Demonstrates Efficacy in Ulcerative Colitis Regardless of Prior Advanced Therapy Exposure
05/05/2026
Jessica Garlewicz
While response rates were generally higher in patients without prior advanced therapy failure, meaningful improvements were still seen in those with treatment-resistant disease.
While response rates were generally higher in patients without prior advanced therapy failure, meaningful improvements were still seen in those with treatment-resistant disease.
While response rates were...
05/05/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Early “Top-Down” Therapy Reduces Long-Term Complications in Crohn’s Disease
05/05/2026
Jessica Garlewicz
Disease progression and hospitalizations were more common in the step-up group, with higher rates of stricturing and penetrating complications.
Disease progression and hospitalizations were more common in the step-up group, with higher rates of stricturing and penetrating complications.
Disease progression and...
05/05/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Upper GI Crohn’s Disease Remains Underrecognized, Lacks Standardized Guidance
04/02/2026
Jessica Garlewicz
A recent review noted a lack of consistent diagnostic definitions across modalities, complicating clinical interpretation and research comparisons.
A recent review noted a lack of consistent diagnostic definitions across modalities, complicating clinical interpretation and research comparisons.
A recent review noted a lack of...
04/02/2026
Advances in Inflammatory Bowel Disease Network
Research Summary
Advanced Therapy May Reduce Antibiotic Dependence in Chronic Pouchitis After IPAA
03/18/2026
Jessica Garlewicz
These findings support considering immune-mediated therapy in selected patients although more research is needed to identify the patients likely to benefit most from advanced therapy.
These findings support considering immune-mediated therapy in selected patients although more research is needed to identify the patients likely to benefit most from advanced therapy.
These findings support...
03/18/2026
Advances in Inflammatory Bowel Disease Network
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
News
Medicare Will Cover GLP-1s for Obesity Under Deal with Pharma
11/06/2025
Rebecca Mashaw
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said...
11/06/2025
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Updated Indication for Upadacitinib in IBD
10/14/2025
Rebecca Mashaw
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for...
10/14/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive Time
Podcast
IBD Drive Time: Florian Rieder, MD, on Stricturing and Penetrating Crohn's Disease
10/06/2025
Raymond Cross, MD; Florian Rieder
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes...
10/06/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Guidelines
IBD Drive Time: Anita Afzali, MD, on the ACG Guidelines for Crohn's Disease
08/18/2025
Raymond Cross, MD; Anita Afzali
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology.
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology.
Dr Anita Afzali reviews with Dr...
08/18/2025
Advances in Inflammatory Bowel Disease Network
IBD logo
Podcast
IBD Drive Time: Importance of Diet in the Management of Crohn's Disease
05/25/2023
Raymond Cross, MD; James D. Lewis
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD...
05/25/2023
Advances in Inflammatory Bowel Disease Network
Saurabh Mehandru
Podcast
Saurabh Mehandru, MD, on Durability of Response to p19 Inhibitors in IBD
03/24/2023
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results...
03/24/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sara Horst, MD, on Risankizumab for Crohn Disease
07/12/2022
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive...
07/12/2022
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Podcast
Phillip Fleshner, MD, on Perianal/Fistulizing Crohn's Disease
04/30/2022
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip...
04/30/2022
Advances in Inflammatory Bowel Disease Network
David Schwartz, MD
Podcasts
David Schwartz, MD, on the ENTERPRISE Study of Vedolizumab for Perianal Crohn Disease
12/30/2021
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz,...
12/30/2021
Advances in Inflammatory Bowel Disease Network
Adam Cheifetz
Podcast
Adam Cheifetz, MD, and Konstantinos Papamichail, MD, on Therapeutic Drug Monitoring in Fistulizing Crohn Disease
09/03/2021
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz,...
09/03/2021
Advances in Inflammatory Bowel Disease Network
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
05/07/2021
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst...
05/07/2021
Advances in Inflammatory Bowel Disease Network
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
04/26/2021
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David...
04/26/2021
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jennifer Seminerio, MD, on Advanced Combination Therapy
06/12/2026
Raymond Cross, MD; Jennifer Seminerio, MD
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss...
06/12/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jordan Axelrad, MD, on Communicating Risks to Patients With IBD
05/22/2026
Raymond Cross, MD; Jordan Axelrad, MD
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan...
05/22/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Colleen Kelly, MD, on Obesity and IBD
04/20/2026
Raymond Cross, MD; Colleen Kelly, MD
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on...
04/20/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jared Magee, MD, on Men's Health in IBD
04/07/2026
Raymond Cross, MD; Jared Magee, MD
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared...
04/07/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: The Best of ECCO 2026
03/25/2026
Raymond Cross, MD; Sara Horst, MD; Jordan Axelrad, MD
Host Raymond Cross, MD, is joined by Drs Sara Horst and Jordan Axelrad to review the findings of their picks for the best presentations from the European Crohn's and Colitis Organization meeting held earlier this year.
Host Raymond Cross, MD, is joined by Drs Sara Horst and Jordan Axelrad to review the findings of their picks for the best presentations from the European Crohn's and Colitis Organization meeting held earlier this year.
Host Raymond Cross, MD, is...
03/25/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Shirley Cohen-Mekelburg, MD on Self-Care for IBD Patients
03/17/2026
Shirley Cohen-Mekelburg; Raymond Cross, MD
Host Raymond Cross, MD, calls on Dr Shirley Mekelburg-Cohen to discuss the importance of self-care among patients with IBD, what self-care consists of, and how to help patients learn to partner with their clinicians in controlling their...
Host Raymond Cross, MD, calls on Dr Shirley Mekelburg-Cohen to discuss the importance of self-care among patients with IBD, what self-care consists of, and how to help patients learn to partner with their clinicians in controlling their...
Host Raymond Cross, MD, calls on...
03/17/2026
Advances in Inflammatory Bowel Disease Network
New IBD Logo
Expert Insights
IBD Drive Time: James Lewis, MD, on Dysplasia Surveillance in IBD
02/23/2026
Raymond Cross, MD; James D. Lewis, MD
Dr James Lewis from the University of Pennsylvania and host Dr Raymond Cross discuss the risk of colon cancer among patients with inflammatory bowel disease, the importance of appropriate surveillance, and special considerations for choosing...
Dr James Lewis from the University of Pennsylvania and host Dr Raymond Cross discuss the risk of colon cancer among patients with inflammatory bowel disease, the importance of appropriate surveillance, and special considerations for choosing...
Dr James Lewis from the...
02/23/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Raymond Cross, MD, on Ostomy Complications
01/13/2026
Raymond Cross, MD; Sara Horst, MD
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive...
01/13/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Conference Coverage
IBD Drive Time: The Best of ACG With Dr Sara Horst
12/01/2025
Raymond Cross, MD; Sara Horst, MD
Dr Sara Horst joins IBD Drive Time host Dr Raymond Cross to review their choices for the best presentations from the American College of Gastroenterology annual meeting.
Dr Sara Horst joins IBD Drive Time host Dr Raymond Cross to review their choices for the best presentations from the American College of Gastroenterology annual meeting.
Dr Sara Horst joins IBD Drive...
12/01/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Freddy Caldera, MD, on Vaccines for Patients With IBD
11/03/2025
Raymond Cross, MD; Freddy Caldera, DO
Freddy Caldera, DO, returns to talk to IBD Drive Time host Raymond Cross, MD, about the best current recommendations for patients with IBD in the midst of controversy and confusion.
Freddy Caldera, DO, returns to talk to IBD Drive Time host Raymond Cross, MD, about the best current recommendations for patients with IBD in the midst of controversy and confusion.
Freddy Caldera, DO, returns to...
11/03/2025
Advances in Inflammatory Bowel Disease Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use